Glucagon-like peptide-1 (GLP-1) peptides have emerged as a compelling therapeutic target for managing metabolic syndromes. These naturally occurring substances are secreted by the gut in response to nutrient intake, https://tirzapatide.com/collections/fda-registered-peptides/products/ghk-cu-peptide